Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to support the Cooperative Human Tissue Network (CHTN).
The goal for CHTN is to collect and distribute high quality human tissue specimens to facilitate basic and early translational cancer
research, as well as assay development.
The CHTN is designed as a unique biospecimen resource in that it is based on prospective collection and distribution of samples upon specific investigators requests.
Samples to be collected from patients include pre-cancerous, cancerous, and benign neoplastic tissues, as well as specimens corresponding to non-neoplastic diseases and uninvolved tissues.
This FOA solicits applications for CHTN awards from institutions/teams capable of contributing to the mission of CHTN by:
(1) providing prospective investigator-defined procurement of high-quality malignant, benign, diseased, and uninvolved (normal adjacent) tissues and fluids from patients throughout North America and elsewhere; (2) assisting individual investigators with regard to specific specimen needs of their research; (3) assisting in developing and disseminating knowledge on high quality practices for successfully operating a biospecimen repository; and (4) educating the community about the importance of the availability of high quality human tissue specimens for medical research.
Depending on their profile and capabilities, applicants must indicate whether they propose to function as the CHTN adult biospecimen division or the pediatric specimen division.
Nonetheless, it will be acceptable for an adult biospecimen division, if capable, to contribute pediatric samples for networked requests.
This FOA is open to all qualified applicants irrespective of their previous association with the CHTN.
The goal for CHTN is to collect and distribute high quality human tissue specimens to facilitate basic and early translational cancer
research, as well as assay development.
The CHTN is designed as a unique biospecimen resource in that it is based on prospective collection and distribution of samples upon specific investigators requests.
Samples to be collected from patients include pre-cancerous, cancerous, and benign neoplastic tissues, as well as specimens corresponding to non-neoplastic diseases and uninvolved tissues.
This FOA solicits applications for CHTN awards from institutions/teams capable of contributing to the mission of CHTN by:
(1) providing prospective investigator-defined procurement of high-quality malignant, benign, diseased, and uninvolved (normal adjacent) tissues and fluids from patients throughout North America and elsewhere; (2) assisting individual investigators with regard to specific specimen needs of their research; (3) assisting in developing and disseminating knowledge on high quality practices for successfully operating a biospecimen repository; and (4) educating the community about the importance of the availability of high quality human tissue specimens for medical research.
Depending on their profile and capabilities, applicants must indicate whether they propose to function as the CHTN adult biospecimen division or the pediatric specimen division.
Nonetheless, it will be acceptable for an adult biospecimen division, if capable, to contribute pediatric samples for networked requests.
This FOA is open to all qualified applicants irrespective of their previous association with the CHTN.
Related Programs
Department of Health and Human Services
Cancer Cause and Prevention Research
Department of Health and Human ServicesDepartment of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $304,253
Office: National Institutes of Health
Estimated Funding: $304,253
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-025.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-025.html
Contact:
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
Date Posted:
2018-06-22
Application Due Date:
Archive Date:
2018-10-03
Social Entrepreneurship
Spotlight
This Social Innovation Helps Prevent Bed Sores in Wheelchair Users
Co-founders William Mann and David Mravyan devised the Sensimat during a mandatory project for their MBA at the Richard Ivey School of Business in Canada. Sensimat is a device that helps manage and assess pressure among wheelchair users.
Learn How to Identify and Avoid Grant Scams
